Učitavanje...
2371 Validation of a novel PD-L1 assay for bladder cancer circulating tumor cells
OBJECTIVES/SPECIFIC AIMS: Bladder cancer patients being considered for immune checkpoint blockade are often judged on immunohistochemical staining for the checkpoint target protein PD-L1 in the original surgery or biopsy sample. However, sampling error or the clinical evolution of most patients’ can...
Spremljeno u:
| Izdano u: | J Clin Transl Sci |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Cambridge University Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6798935/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/cts.2018.150 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|